Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)

Paclitaxel‐induced peripheral neuropathy (PIPN) cannot be predicted from clinical parameters and might have a pharmacogenomic basis. Previous studies identified single nucleotide variants (SNV) associated with PIPN. However, only a subset of findings has been confirmed to date in more than one study...

Descripción completa

Detalles Bibliográficos
Autores principales: Boora, Ganesh K., Kanwar, Rahul, Kulkarni, Amit A., Abyzov, Alexej, Sloan, Jeff, Ruddy, Kathryn J., Banck, Michaela S., Loprinzi, Charles L., Beutler, Andreas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831281/
https://www.ncbi.nlm.nih.gov/pubmed/26763541
http://dx.doi.org/10.1002/cam4.625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831281/
https://www.ncbi.nlm.nih.gov/pubmed/26763541
http://dx.doi.org/10.1002/cam4.625

Ejemplares similares